USD891446S1 - Display screen or portion thereof with graphical user interface - Google Patents

Display screen or portion thereof with graphical user interface Download PDF

Info

Publication number
USD891446S1
USD891446S1 US29/694,308 US201929694308F USD891446S US D891446 S1 USD891446 S1 US D891446S1 US 201929694308 F US201929694308 F US 201929694308F US D891446 S USD891446 S US D891446S
Authority
US
United States
Prior art keywords
display screen
user interface
graphical user
ornamental design
graphical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/694,308
Inventor
Alexander Bagaev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BostonGene Corp
Original Assignee
BostonGene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BostonGene Corp filed Critical BostonGene Corp
Priority to US29/694,308 priority Critical patent/USD891446S1/en
Assigned to BOSTONGENE LLC reassignment BOSTONGENE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAGAEV, Alexander
Assigned to BOSTONGENE CORPORATION reassignment BOSTONGENE CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTONGENE LLC
Application granted granted Critical
Publication of USD891446S1 publication Critical patent/USD891446S1/en
Assigned to BOSTONGENE LLC reassignment BOSTONGENE LLC CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED ON REEL 051107 FRAME 0253. ASSIGNOR(S) HEREBY CONFIRMS THE THE CORRECT ASSIGNMENT DOCUMENT FROM ALEXANDER BAGAEV TO BOSTONGENE LLC IS SUBMITTED HEREWITH. Assignors: BAGAEV, Alexander
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
    • G06F16/28—Databases characterised by their database models, e.g. relational or object models
    • G06F16/284—Relational databases
    • G06F16/285—Clustering or classification
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/20—Probabilistic models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Description

The FIGURE is a front view of a display screen or portion thereof with graphical user interface showing the claimed design.
The broken lines showing the display screen or portion thereof and graphical elements within the display screen form no part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for a display screen or portion thereof with graphical user interface, as shown and described.
US29/694,308 2017-06-13 2019-06-10 Display screen or portion thereof with graphical user interface Active USD891446S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/694,308 USD891446S1 (en) 2017-06-13 2019-06-10 Display screen or portion thereof with graphical user interface

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762518787P 2017-06-13 2017-06-13
US201762598440P 2017-12-13 2017-12-13
US16/006,462 US11367509B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US29/694,308 USD891446S1 (en) 2017-06-13 2019-06-10 Display screen or portion thereof with graphical user interface

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US16/006,462 Continuation US11367509B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles

Publications (1)

Publication Number Publication Date
USD891446S1 true USD891446S1 (en) 2020-07-28

Family

ID=62779138

Family Applications (27)

Application Number Title Priority Date Filing Date
US16/006,381 Abandoned US20180358125A1 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,518 Active 2041-05-02 US11430545B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,462 Active 2040-08-30 US11367509B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,340 Active US10340031B2 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,200 Abandoned US20180358132A1 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,593 Active US11322226B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,129 Active US10720230B2 (en) 2017-06-13 2018-06-12 Method for administering a checkpoint blockade therapy to a subject
US16/006,572 Active US10650911B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,481 Pending US20200175134A9 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,085 Abandoned US20180357361A1 (en) 2017-06-13 2018-06-12 Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
US16/006,279 Active US10340030B2 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,555 Active US10311967B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/391,221 Active US10395761B1 (en) 2017-06-13 2019-04-22 Systems and methods for generating, visualizing and classifying molecular functional profiles
US29/694,310 Active USD890779S1 (en) 2017-06-13 2019-06-10 Display screen or portion thereof with graphical user interface
US29/694,308 Active USD891446S1 (en) 2017-06-13 2019-06-10 Display screen or portion thereof with graphical user interface
US16/456,462 Active 2039-04-29 US11842797B2 (en) 2017-06-13 2019-06-28 Systems and methods for predicting therapy efficacy from normalized biomarker scores
US16/456,370 Active US10504615B2 (en) 2017-06-13 2019-06-28 Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interface
US16/523,808 Active US10580517B2 (en) 2017-06-13 2019-07-26 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/662,280 Active US10636513B2 (en) 2017-06-13 2019-10-24 Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interface
US16/676,375 Active US10636514B2 (en) 2017-06-13 2019-11-06 Using subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and therapy scores
US16/696,128 Active US10706954B2 (en) 2017-06-13 2019-11-26 Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
US16/856,566 Active US11004542B2 (en) 2017-06-13 2020-04-23 Using subject sequencing data and a database of therapy biomarker distributions to determine therapy impact
US16/871,755 Active US11302420B2 (en) 2017-06-13 2020-05-11 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/920,226 Active US11373733B2 (en) 2017-06-13 2020-07-02 Systems and methods for generating, visualizing and classifying molecular functional profiles
US17/237,672 Active US11705220B2 (en) 2017-06-13 2021-04-22 Systems and methods for identifying cancer treatments from normalized biomarker scores
US17/699,018 Pending US20220389512A1 (en) 2017-06-13 2022-03-18 Systems and methods for generating, visualizing and classifying molecular functional profiles
US18/460,330 Pending US20240006029A1 (en) 2017-06-13 2023-09-01 Systems and methods for predicting therapy efficacy from normalized biomarker scores

Family Applications Before (14)

Application Number Title Priority Date Filing Date
US16/006,381 Abandoned US20180358125A1 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,518 Active 2041-05-02 US11430545B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,462 Active 2040-08-30 US11367509B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,340 Active US10340031B2 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,200 Abandoned US20180358132A1 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,593 Active US11322226B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,129 Active US10720230B2 (en) 2017-06-13 2018-06-12 Method for administering a checkpoint blockade therapy to a subject
US16/006,572 Active US10650911B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,481 Pending US20200175134A9 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/006,085 Abandoned US20180357361A1 (en) 2017-06-13 2018-06-12 Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
US16/006,279 Active US10340030B2 (en) 2017-06-13 2018-06-12 Systems and methods for identifying cancer treatments from normalized biomarker scores
US16/006,555 Active US10311967B2 (en) 2017-06-13 2018-06-12 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/391,221 Active US10395761B1 (en) 2017-06-13 2019-04-22 Systems and methods for generating, visualizing and classifying molecular functional profiles
US29/694,310 Active USD890779S1 (en) 2017-06-13 2019-06-10 Display screen or portion thereof with graphical user interface

Family Applications After (12)

Application Number Title Priority Date Filing Date
US16/456,462 Active 2039-04-29 US11842797B2 (en) 2017-06-13 2019-06-28 Systems and methods for predicting therapy efficacy from normalized biomarker scores
US16/456,370 Active US10504615B2 (en) 2017-06-13 2019-06-28 Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interface
US16/523,808 Active US10580517B2 (en) 2017-06-13 2019-07-26 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/662,280 Active US10636513B2 (en) 2017-06-13 2019-10-24 Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interface
US16/676,375 Active US10636514B2 (en) 2017-06-13 2019-11-06 Using subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and therapy scores
US16/696,128 Active US10706954B2 (en) 2017-06-13 2019-11-26 Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
US16/856,566 Active US11004542B2 (en) 2017-06-13 2020-04-23 Using subject sequencing data and a database of therapy biomarker distributions to determine therapy impact
US16/871,755 Active US11302420B2 (en) 2017-06-13 2020-05-11 Systems and methods for generating, visualizing and classifying molecular functional profiles
US16/920,226 Active US11373733B2 (en) 2017-06-13 2020-07-02 Systems and methods for generating, visualizing and classifying molecular functional profiles
US17/237,672 Active US11705220B2 (en) 2017-06-13 2021-04-22 Systems and methods for identifying cancer treatments from normalized biomarker scores
US17/699,018 Pending US20220389512A1 (en) 2017-06-13 2022-03-18 Systems and methods for generating, visualizing and classifying molecular functional profiles
US18/460,330 Pending US20240006029A1 (en) 2017-06-13 2023-09-01 Systems and methods for predicting therapy efficacy from normalized biomarker scores

Country Status (12)

Country Link
US (27) US20180358125A1 (en)
EP (5) EP3639169B1 (en)
JP (8) JP6812580B2 (en)
KR (1) KR102396784B1 (en)
CN (2) CN111052247A (en)
AU (4) AU2018282759A1 (en)
CA (3) CA3065193A1 (en)
DE (1) DE112018002990T5 (en)
GB (5) GB2576680B (en)
IL (3) IL270886A (en)
SG (2) SG10201911680SA (en)
WO (3) WO2018231772A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWD216917S (en) 2020-12-11 2022-02-01 股感媒體科技股份有限公司 Graphical User Interface for Display Panel

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11497476B2 (en) * 2015-06-22 2022-11-15 Sunnybrook Research Institute Systems and methods for prediction of tumor treatment response to using texture derivatives computed from quantitative ultrasound parameters
EP3310260A4 (en) * 2015-06-22 2019-03-06 Sunnybrook Research Institute Systems and methods for prediction of tumor response to chemotherapy using pre-treatment quantitative ultrasound parameters
MX2019005955A (en) 2016-11-22 2019-07-10 Hyperfine Res Inc Systems and methods for automated detection in magnetic resonance images.
US10627464B2 (en) 2016-11-22 2020-04-21 Hyperfine Research, Inc. Low-field magnetic resonance imaging methods and apparatus
GB2576680B (en) * 2017-06-13 2022-03-23 Bostongene Corp Systems and methods for generating, visualizing and classifying molecular functional profiles
US11505831B2 (en) * 2017-12-20 2022-11-22 Dana-Farber Cancer Institute, Inc. Compositions and methods comprising digital signatures to predict response and resistance to targeted therapy and immunotherapy
US11335464B2 (en) * 2018-01-12 2022-05-17 Siemens Medical Solutions Usa, Inc. Integrated precision medicine by combining quantitative imaging techniques with quantitative genomics for improved decision making
KR20200143462A (en) 2018-04-13 2020-12-23 프리놈 홀딩스, 인크. Implementing machine learning for testing multiple analytes in biological samples
US11475995B2 (en) 2018-05-07 2022-10-18 Perthera, Inc. Integration of multi-omic data into a single scoring model for input into a treatment recommendation ranking
US11348661B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US11348240B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US11348239B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US10957041B2 (en) 2018-05-14 2021-03-23 Tempus Labs, Inc. Determining biomarkers from histopathology slide images
WO2019222289A1 (en) 2018-05-14 2019-11-21 Tempus Labs, Inc. A generalizable and interpretable deep learning framework for predicting msi from histopathology slide images
US11574718B2 (en) * 2018-05-31 2023-02-07 Perthera, Inc. Outcome driven persona-typing for precision oncology
USD887431S1 (en) * 2018-06-18 2020-06-16 Genomic Prediction, Inc. Display screen with graphical user interface
USD896241S1 (en) * 2018-12-03 2020-09-15 Illumina, Inc. Display screen or portion thereof with graphical user interface
CN109712716B (en) * 2018-12-25 2021-08-31 广州医科大学附属第一医院 Disease influence factor determination method, system and computer equipment
CA3125386A1 (en) * 2018-12-31 2020-07-09 Tempus Labs, Inc. Transcriptome deconvolution of metastatic tissue samples
USD910706S1 (en) 2019-01-31 2021-02-16 Driv Ip, Llc Display screen with graphical user interface
WO2020172592A1 (en) * 2019-02-22 2020-08-27 Mitra Rxdx, Inc. A method to predict a patient's response to an anti-cancer drug from a ratio of expression levels of two sets of genes
JP2022521791A (en) 2019-02-26 2022-04-12 テンパス ラブズ，インコーポレイテッド Systems and methods for using sequencing data for pathogen detection
CN111621564B (en) * 2019-02-28 2022-03-25 武汉大学 Method for identifying effective tumor neoantigen
WO2020180424A1 (en) 2019-03-04 2020-09-10 Iocurrents, Inc. Data compression and communication using machine learning
WO2020231937A1 (en) * 2019-05-10 2020-11-19 University Of Massachusetts Irf2 as a prognostic biomarker and target for augmenting immunotherapy
US11527323B2 (en) 2019-05-14 2022-12-13 Tempus Labs, Inc. Systems and methods for multi-label cancer classification
USD891445S1 (en) 2019-06-10 2020-07-28 Bostongene Corporation Display screen or portion thereof with graphical user interface
USD892825S1 (en) 2019-06-10 2020-08-11 Bostongene Corporation Display screen or portion thereof with graphical user interface
EP3984037A1 (en) * 2019-06-13 2022-04-20 F. Hoffmann-La Roche AG Systems and methods with improved user interface for interpreting and visualizing longitudinal data
CN110309382B (en) * 2019-06-17 2021-05-28 暨南大学 Mobile application homology edge clustering method based on multi-dimensional features
WO2021003246A1 (en) * 2019-07-01 2021-01-07 Accure Health Inc. Predictive liquid markers for cancer immunotherapy
US20210005283A1 (en) 2019-07-03 2021-01-07 Bostongene Corporation Techniques for bias correction in sequence data
AU2020313915A1 (en) * 2019-07-12 2022-02-24 Tempus Ai, Inc. Adaptive order fulfillment and tracking methods and systems
US10581851B1 (en) * 2019-07-17 2020-03-03 Capital One Services, Llc Change monitoring and detection for a cloud computing environment
US11379757B2 (en) * 2019-07-31 2022-07-05 BioSymetrics, Inc. Methods, systems, and frameworks for data analytics using machine learning
CN110277135B (en) * 2019-08-10 2021-06-01 杭州新范式生物医药科技有限公司 Method and system for selecting individualized tumor neoantigen based on expected curative effect
WO2021030193A1 (en) * 2019-08-13 2021-02-18 Nantomics, Llc System and method for classifying genomic data
JP2022544604A (en) 2019-08-16 2022-10-19 テンパス・ラボズ・インコーポレイテッド Systems and methods for detecting cellular pathway dysregulation in cancer specimens
CN110716171A (en) * 2019-08-28 2020-01-21 上海无线电设备研究所 Polarization DOA joint estimation method based on genetic algorithm
EP3799057A1 (en) * 2019-09-25 2021-03-31 Koninklijke Philips N.V. Prediction tool for patient immune response to a therapy
US20220347180A1 (en) * 2019-09-27 2022-11-03 The Regents Of The University Of Colorado, A Body Corporate Enhancing cancer therapy treatment with bh3 mimetics
WO2021076960A1 (en) * 2019-10-16 2021-04-22 Anand Rene Live virus vaccine injury risk
EP4058593A4 (en) * 2019-11-12 2023-11-15 Foundation Medicine, Inc. Methods of detecting a fusion gene encoding a neoantigen
CN110938627B (en) * 2019-11-25 2021-07-06 西安交通大学第二附属医院 Use of an ESCO2 inhibitor for the manufacture of a medicament for the treatment of hypopharyngeal cancer
TWI709904B (en) * 2019-11-26 2020-11-11 國立中央大學 Methods for training an artificial neural network to predict whether a subject will exhibit a characteristic gene expression and systems for executing the same
JP2023504555A (en) 2019-12-05 2023-02-03 ボストンジーン コーポレイション Machine learning techniques for gene expression analysis
CN116003601A (en) * 2019-12-05 2023-04-25 启愈生物技术(上海)有限公司 anti-PD-L1 nano antibody and application thereof
CA3163492A1 (en) 2019-12-12 2021-06-17 Tempus Labs, Inc. Real-world evidence of diagnostic testing and treatment patterns in u.s. breast cancer patients
JP2023509540A (en) * 2020-01-07 2023-03-08 コリア アドバンスド インスティテュート オブ サイエンス アンド テクノロジー Methods, systems and uses thereof for screening neoantigens
US20230054656A1 (en) * 2020-02-05 2023-02-23 Board Of Regents, The University Of Texas System Diagnostic and prognostic utility of exosomes in immunotherapy
CN111292542B (en) * 2020-02-24 2021-08-31 深圳市综合交通设计研究院有限公司 Signal lamp system and control method thereof
CN111354420B (en) * 2020-03-08 2020-12-22 吉林大学 siRNA research and development method for COVID-19 virus drug therapy
US20210363592A1 (en) * 2020-03-11 2021-11-25 Vanderbilt University Detection of Signatures in a Breast Cancer Subject
US20230146730A1 (en) 2020-03-19 2023-05-11 Chugai Seiyaku Kabushiki Kaisha Biomarkers for predicting the response to checkpoint inhibitors
WO2021205274A1 (en) * 2020-04-08 2021-10-14 Immunitybio, Inc. Methods for assessing chemokine activity
IL297812A (en) * 2020-04-30 2022-12-01 Caris Mpi Inc Immunotherapy response signature
TW202211250A (en) * 2020-05-26 2022-03-16 南韓商愛思阿爾法數字醫療科技有限公司 System for treating cancer cachexia, computing system for treating cancer cachexia and operating method thereof, and non-transitory readable medium
CN111863137B (en) * 2020-05-28 2024-01-02 上海朴岱生物科技合伙企业（有限合伙） Complex disease state evaluation method based on high-throughput sequencing data and clinical phenotype construction and application
CN111755073B (en) * 2020-05-31 2022-11-15 复旦大学 Transcriptome-based PD-1 therapy treatment effect prediction system
JP2021197100A (en) * 2020-06-18 2021-12-27 国立研究開発法人産業技術総合研究所 Information processing system, information processing method, identification method and program
CN111863120B (en) * 2020-06-28 2022-05-13 深圳晶泰科技有限公司 Medicine virtual screening system and method for crystal compound
WO2022010866A1 (en) 2020-07-06 2022-01-13 Bostongene Corporation Tumor microenvironment-based methods for assessing car-t and other immunotherapies
AU2021314061A1 (en) * 2020-07-23 2023-03-16 The DNA Company Inc. Systems and methods for determining a physiological profile using genetic information
WO2022016447A1 (en) * 2020-07-23 2022-01-27 碳逻辑生物科技(香港)有限公司 Marker for assessing responsiveness of colorectal cancer patients to immunotherapeutic drug
WO2022031620A2 (en) * 2020-08-01 2022-02-10 Aigene Methods for the rapid assessment of the efficacy of cancer therapy and related applications
CN112147326B (en) * 2020-09-04 2022-04-08 北京大学 Accurate detection kit for tumor immune cell subset typing
CN112086199B (en) * 2020-09-14 2023-06-09 中科院计算所西部高等技术研究院 Liver cancer data processing system based on multiple groups of study data
WO2022089426A1 (en) * 2020-10-27 2022-05-05 细胞图谱有限公司 Method for analyzing peripheral blood sample and kit
CN112637134A (en) * 2020-12-02 2021-04-09 电子科技大学 Signal sorting method for time hopping signals of data link communication system
CN112530581B (en) * 2020-12-03 2023-11-21 安徽医科大学第一附属医院 Immune molecule classification system for prostate cancer patients and application thereof
US20220186318A1 (en) 2020-12-11 2022-06-16 Bostongene Corporation Techniques for identifying follicular lymphoma types
CN112635063B (en) * 2020-12-30 2022-05-24 华南理工大学 Comprehensive lung cancer prognosis prediction model, construction method and device
US20240085417A1 (en) * 2021-01-20 2024-03-14 Memorial Sloan Kettering Cancer Center Peripheral blood phenotype linked to outcomes after immunotherapy treatment
JP2022112097A (en) * 2021-01-21 2022-08-02 キヤノンメディカルシステムズ株式会社 Medical information processing apparatus
CN112735520B (en) * 2021-02-03 2021-07-20 深圳裕康医学检验实验室 Interpretation method, system and storage medium for tumor individualized immunotherapy gene detection result
CN112863595A (en) * 2021-03-08 2021-05-28 中国农业科学院兰州畜牧与兽药研究所 Method for excavating Tibetan sheep high-altitude hypoxia adaptability related gene based on MeRIP-Seq technology
US20220310230A1 (en) * 2021-03-08 2022-09-29 Venn Biosciences Corporation Biomarkers for determining an immuno-onocology response
EP4305208A1 (en) 2021-03-09 2024-01-17 BostonGene Corporation B cell-enriched tumor microenvironments
WO2022192399A1 (en) 2021-03-09 2022-09-15 Bostongene Corporation Gastric cancer tumor microenvironments
US20220319638A1 (en) 2021-03-09 2022-10-06 Bostongene Corporation Predicting response to treatments in patients with clear cell renal cell carcinoma
WO2022192904A1 (en) * 2021-03-12 2022-09-15 Vast Life Sciences Inc. Systems and methods for identifying microbial biosynthetic genetic clusters
CN112698044B (en) * 2021-03-23 2021-06-22 信纳克(北京)生化标志物检测医学研究有限责任公司 Device and method for evaluating immune state after targeted therapy
US11931127B1 (en) 2021-04-08 2024-03-19 T-Mobile Usa, Inc. Monitoring users biological indicators using a 5G telecommunication network
US20220375543A1 (en) 2021-05-18 2022-11-24 Bostongene Corporation Techniques for single sample expression projection to an expression cohort sequenced with another protocol
WO2023017525A1 (en) * 2021-08-11 2023-02-16 OncoHost Ltd. Predicting patient response
WO2023055657A1 (en) * 2021-09-30 2023-04-06 Selonterra, Inc. Use of c9orf72 -mediated genes for diagnosis and treatment of neuronal diseases
WO2023076574A1 (en) 2021-10-29 2023-05-04 Bostongene Corporation Tumor microenvironment types in breast cancer
WO2023089597A2 (en) * 2021-11-22 2023-05-25 Venn Biosciences Corporation Predicting sarcoma treatment response using targeted quantification of site-specific protein glycosylation
WO2023097300A1 (en) * 2021-11-23 2023-06-01 Curematch Inc. Clinical trial optimization
US20230178200A1 (en) * 2021-12-03 2023-06-08 Digital Diagnostics Inc. Direct medical treatment predictions using artificial intelligence
WO2023137401A1 (en) * 2022-01-13 2023-07-20 Synthorx, Inc. Methods for selecting subjects and treating cancer with il-2 therapy
WO2023154549A1 (en) 2022-02-14 2023-08-17 Bostongene Corporation Urothelial tumor microenvironment (tme) types
WO2023194090A1 (en) 2022-04-08 2023-10-12 Bayer Aktiengesellschaft Multiple instance learning considering neighborhood aggregations
WO2023208663A1 (en) 2022-04-26 2023-11-02 Bayer Aktiengesellschaft Multiple-instance learning based on regional embeddings
WO2023213623A1 (en) 2022-05-03 2023-11-09 Bayer Aktiengesellschaft Dynamic sampling strategy for multiple-instance learning
WO2024025923A1 (en) * 2022-07-26 2024-02-01 Washington University Methods for selection of cancer patients for anti-angiogenic and immune checkpoint blockade therapies and combinations thereof
WO2024033930A1 (en) * 2022-08-11 2024-02-15 OncoHost Ltd. Predicting patient response
WO2024054951A1 (en) * 2022-09-08 2024-03-14 Cardiff Oncology, Inc. Methods of monitoring mutations in treatment of colorectal cancer
CN116248680B (en) * 2023-05-11 2023-08-01 湖南工商大学 De novo peptide sequencing method, de novo peptide sequencing device and related equipment
CN117095743B (en) * 2023-10-17 2024-01-05 山东鲁润阿胶药业有限公司 Polypeptide spectrum matching data analysis method and system for small molecular peptide donkey-hide gelatin
CN117542529B (en) * 2024-01-10 2024-04-02 北京博富瑞基因诊断技术有限公司 Method, system, device and storage medium for predicting non-recurrent death risk of HLA-incompatible allogeneic hematopoietic stem cell transplantation

Citations (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD496297S1 (en) * 2003-11-13 2004-09-21 Susan M. Kahil Face for a timepiece
US20120005631A1 (en) * 2010-06-30 2012-01-05 Oracle International Corporation Techniques for display of information related to policies
USD697080S1 (en) * 2010-02-26 2014-01-07 Draeger Medical Systems, Inc. Display screen with an icon
USD708193S1 (en) * 2013-08-30 2014-07-01 Nike, Inc. Display screen with graphical user interface
USD711420S1 (en) * 2014-03-14 2014-08-19 Nike, Inc. Display screen with graphical user interface for athletic achievements
USD719177S1 (en) * 2012-12-27 2014-12-09 Jason M. Cohen Display screen or portion thereof with graphical user interface
USD725148S1 (en) * 2013-04-30 2015-03-24 Microsoft Corporation Display screen with animated icon
USD735732S1 (en) * 2013-03-12 2015-08-04 Hewlett-Packard Development Company, L.P. Display screen with graphical user interface
USD741912S1 (en) * 2013-05-29 2015-10-27 Microsoft Corporation Display screen with animated graphical user interface
USD743424S1 (en) * 2013-06-04 2015-11-17 Abbyy Infopoisk Llc Display screen or portion thereof with graphical user interface
USD743413S1 (en) * 2012-09-19 2015-11-17 ABBYY InfoPiosk LLC Display screen or portion thereof with graphical user interface
USD743423S1 (en) * 2013-06-04 2015-11-17 Abbyy Infopoisk Llc Display screen or portion thereof with graphical user interface
USD744500S1 (en) * 2013-07-05 2015-12-01 Lg Electronics Inc. Display screen with transitional graphical user interface
USD755240S1 (en) * 2013-06-09 2016-05-03 Apple Inc. Display screen or portion thereof with graphical user interface
USD759076S1 (en) * 2014-04-18 2016-06-14 Nutonian, Inc. Display screen with graphical user interface
USD765673S1 (en) * 2014-12-30 2016-09-06 Energous Corporation Display screen with graphical user interface
USD771063S1 (en) * 2014-02-21 2016-11-08 Huawei Device Co., Ltd. Display screen or portion thereof with animated graphical user interface
USD772241S1 (en) * 2014-03-19 2016-11-22 Symantec Corporation Display screen or portion thereof with transitional graphical user interface
USD783656S1 (en) * 2015-10-28 2017-04-11 SynerScope B.V. Display screen with graphical user interface
USD784402S1 (en) * 2015-02-04 2017-04-18 Sengled Optoelectronics Co., Ltd Display screen with animated graphical user interface
USD795922S1 (en) * 2015-11-05 2017-08-29 Samsung Electronics Co., Ltd. Display screen or portion thereof with animated graphical user interface
USD797783S1 (en) * 2014-09-02 2017-09-19 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD799516S1 (en) * 2015-12-23 2017-10-10 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD801368S1 (en) * 2014-09-02 2017-10-31 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD802611S1 (en) * 2016-04-14 2017-11-14 Alpha Dominche Holdings, Inc. Beverage brewer display screen with graphical user interface
USD803249S1 (en) * 2016-03-16 2017-11-21 Panasonic Intellectual Property Management Co., Ltd. Display screen portion with graphical user interface for a vehicle
USD803849S1 (en) * 2014-09-02 2017-11-28 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD805535S1 (en) * 2013-06-04 2017-12-19 Abbyy Production Llc Display screen or portion thereof with a transitional graphical user interface
USD806120S1 (en) * 2016-10-31 2017-12-26 Agile Transformation, Inc. Display screen or portion thereof with icon
USD807913S1 (en) * 2016-03-17 2018-01-16 Lg Electronics Inc. Display panel with transitional graphical user interface
USD807906S1 (en) * 2014-09-01 2018-01-16 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD809525S1 (en) * 2013-09-23 2018-02-06 Bally Gaming, Inc. Display screen with an animated graphical user interface for a baccarat game
USD809543S1 (en) * 2014-09-02 2018-02-06 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD809535S1 (en) * 2015-10-06 2018-02-06 Lg Electronics Inc. Vehicle dashboard display screen with an animated graphical user interface
USD810757S1 (en) * 2016-02-19 2018-02-20 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD813250S1 (en) * 2016-08-30 2018-03-20 Ponsse Oyj Display screen with graphical user interface
USD813249S1 (en) * 2017-02-22 2018-03-20 Banuba Limited Display screen with an animated graphical user interface
USD813888S1 (en) * 2016-02-04 2018-03-27 Coway Co., Ltd. Display screen with graphical user interface
USD818494S1 (en) * 2017-06-04 2018-05-22 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD822059S1 (en) * 2017-06-05 2018-07-03 Apple Inc. Display screen or portion thereof with graphical user interface
USD822705S1 (en) * 2017-04-20 2018-07-10 Palantir Technologies, Inc. Display screen or portion thereof with graphical user interface
USD829730S1 (en) * 2016-11-10 2018-10-02 Karma Automotive Llc Display screen with an infotainment graphical user interface
USD832283S1 (en) * 2017-03-28 2018-10-30 Akamai Technologies, Inc. Display screen with animated graphical user interface
USD833471S1 (en) * 2017-08-18 2018-11-13 Salesforce.Com, Inc. Display screen or portion thereof with animated graphical user interface
USD835121S1 (en) * 2016-06-15 2018-12-04 Sony Interactive Entertainment Europe Limited Display screen or portion thereof with graphical user interface
US20180358118A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for identifying cancer treatments from normalized biomarker scores
USD840415S1 (en) * 2017-08-25 2019-02-12 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD840413S1 (en) * 2016-08-15 2019-02-12 Facebook, Inc. Display screen or portion thereof with digital visual codes graphical user interface
USD847857S1 (en) * 2016-10-31 2019-05-07 Agile Transformation, Inc. Display screen or portion thereof with icon
USD850482S1 (en) * 2016-06-11 2019-06-04 Apple Inc. Display screen or portion thereof with graphical user interface
USD850470S1 (en) * 2014-09-01 2019-06-04 Apple Inc. Display screen or portion thereof with graphical user interface
USD852209S1 (en) * 2016-08-24 2019-06-25 Beijing Kingsoft Internet Security Software Co., Ltd. Mobile communication terminal with animated graphical user interface
USD852820S1 (en) * 2018-01-19 2019-07-02 Mouth Player Inc. Display screen or portion thereof with animated graphical user interface
USD855073S1 (en) * 2019-04-05 2019-07-30 Le-Vel Brands, Llc Display screen with icon
USD855629S1 (en) * 2015-10-23 2019-08-06 Sony Corporation Display panel or screen or portion thereof with an animated graphical user interface
USD858531S1 (en) * 2015-03-06 2019-09-03 Apple Inc. Display screen or portion thereof with graphical user interface
USD860228S1 (en) * 2017-09-05 2019-09-17 Byton Limited Display screen with a graphical user interface
USD860251S1 (en) * 2013-06-09 2019-09-17 Apple Inc. Display screen or portion thereof with graphical user interface
USD861022S1 (en) * 2017-10-13 2019-09-24 Honeywell International Inc. Display screen or portion thereof with a graphical user interface
USD861020S1 (en) * 2013-09-10 2019-09-24 Apple Inc. Display screen or portion thereof with graphical user interface
USD862519S1 (en) * 2015-11-18 2019-10-08 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD863325S1 (en) * 2013-12-02 2019-10-15 Dials, LLC Display screen or portion thereof with a graphical user interface
USD865776S1 (en) * 2016-11-18 2019-11-05 Luis Miguel Porturas Display screen with graphical user interface
USD865807S1 (en) * 2018-07-24 2019-11-05 Magic Leap, Inc. Display panel or portion thereof with a graphical user interface
USD868094S1 (en) * 2018-08-30 2019-11-26 Apple Inc. Electronic device with graphical user interface
USD868103S1 (en) * 2017-09-27 2019-11-26 Toyota Research Institute, Inc. Display screen or portion thereof with an animated graphical user interface
USD868812S1 (en) * 2018-02-16 2019-12-03 Early Warning Services, Llc Display screen portion with animated graphical user interface for transmittal notification
USD868811S1 (en) * 2018-02-22 2019-12-03 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD870763S1 (en) * 2018-01-05 2019-12-24 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD871437S1 (en) * 2017-08-22 2019-12-31 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD873294S1 (en) * 2015-03-06 2020-01-21 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD873854S1 (en) * 2017-11-24 2020-01-28 Fujifilm Corporation Display screen or portion thereof with transitional icon
USD874488S1 (en) * 2016-01-05 2020-02-04 Kneevoice, Inc. Display screen or portion thereof with graphical user interface
USD874482S1 (en) * 2018-02-28 2020-02-04 Fujifilm Corporation Display screen or portion thereof with icon
USD877176S1 (en) * 2018-07-24 2020-03-03 Magic Leap, Inc. Display panel or portion thereof with a transitional graphical user interface
USD878393S1 (en) * 2018-01-30 2020-03-17 Magic Leap, Inc. Display panel or portion thereof with a transitional mixed reality graphical user interface
USD879147S1 (en) * 2018-07-31 2020-03-24 Google Llc Display screen with animated icon
USD879112S1 (en) * 2017-11-14 2020-03-24 Geographic Services, Inc. Display screen or portion thereof with graphical user interface
USD879835S1 (en) * 2016-01-19 2020-03-31 Apple Inc. Display screen or portion thereof with set of icons
USD879808S1 (en) * 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
USD880489S1 (en) * 2017-05-18 2020-04-07 The Coca-Cola Company Beverage dispenser display screen or portion thereof with animated graphical user interface
USD882615S1 (en) * 2018-09-06 2020-04-28 Apple Inc. Electronic device with animated graphical user interface
USD882583S1 (en) * 2016-07-12 2020-04-28 Google Llc Display screen with graphical user interface

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US280468A (en) * 1883-07-03 Carrier for store-service apparatus
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
EP0454781B1 (en) 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DE69032284T2 (en) 1989-03-21 1998-10-08 Vical Inc EXPRESSION OF EXOGENOUS POLYNUCLEOTIDE SEQUENCES IN VERTEBLE
EP1001032A3 (en) 1989-08-18 2005-02-23 Chiron Corporation Recombinant retroviruses delivering vector constructs to target cells
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
NZ237464A (en) 1990-03-21 1995-02-24 Depotech Corp Liposomes with at least two separate chambers encapsulating two separate biologically active substances
JP3534749B2 (en) 1991-08-20 2004-06-07 アメリカ合衆国 Adenovirus-mediated gene transfer into the gastrointestinal tract
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
FR2688514A1 (en) 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
WO1993025234A1 (en) 1992-06-08 1993-12-23 The Regents Of The University Of California Methods and compositions for targeting specific tissue
EP0644946A4 (en) 1992-06-10 1997-03-12 Us Health Vector particles resistant to inactivation by human serum.
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
EP0911413A3 (en) 1992-12-03 2000-11-15 Genzyme Corporation Minimal adenovirus-based gene therapy vector
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JP3545403B2 (en) 1993-04-22 2004-07-21 スカイファルマ インコーポレイテッド Cyclodextrin liposomes encapsulating pharmaceutical compounds and methods of use
ATE304604T1 (en) 1993-06-24 2005-09-15 Frank L Graham ADENOVIRUS VECTORS FOR GENE THERAPY
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
DK0814154T3 (en) 1993-09-15 2009-08-31 Novartis Vaccines & Diagnostic Recombinant alphavirus vectors
DE69435223D1 (en) 1993-10-25 2009-09-03 Canji Inc Recombinant adenovirus vector and method of use
RO116341B1 (en) 1993-11-16 2001-01-30 Depotech Corp La Jolia Multivesicle liposome and process for producing the same
ATE381624T1 (en) 1994-05-09 2008-01-15 Oxford Biomedica Ltd RETROVIRAL VECTORS WITH REDUCED RECOMBINATION RATE
WO1996017072A2 (en) 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors
AU2998597A (en) 1996-05-06 1997-11-26 Chiron Corporation Crossless retroviral vectors
EP1158997A2 (en) 1999-03-09 2001-12-05 University Of Southern California Method of promoting myocyte proliferation and myocardial tissue repair
US7905134B2 (en) 2002-08-06 2011-03-15 The Regents Of The University Of California Biomarker normalization
WO2004078035A2 (en) * 2003-02-28 2004-09-16 Bayer Pharmaceuticals Corporation Expression profiles for breast cancer and methods of use
US7858323B2 (en) * 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
US7862995B2 (en) 2004-12-10 2011-01-04 Targeted Molecular Diagnostics Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
WO2006133460A2 (en) 2005-06-09 2006-12-14 Yale University Methods for diagnosing and treating breast cancer based on a her/er ratio
WO2007038792A2 (en) 2005-09-28 2007-04-05 H. Lee Moffitt Cancer Center Individualized cancer treatments
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
NZ544432A (en) * 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
US8068994B2 (en) 2007-07-27 2011-11-29 Wayne State University Method for analyzing biological networks
NZ562237A (en) * 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
US20090105167A1 (en) * 2007-10-19 2009-04-23 Duke University Predicting responsiveness to cancer therapeutics
WO2009146545A1 (en) * 2008-06-05 2009-12-10 University Health Network Compositions and methods for classifying lung cancer and prognosing lung cancer survival
CN102040569B (en) 2009-10-20 2012-11-07 北京绿色金可生物技术股份有限公司 Carotinoid derivatives and preparation method and application thereof
AU2010326066A1 (en) * 2009-12-01 2012-06-21 Compendia Bioscience, Inc. Classification of cancers
WO2011085276A2 (en) * 2010-01-09 2011-07-14 The Translational Genomics Research Institute Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer
WO2012095448A1 (en) 2011-01-11 2012-07-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the outcome of a cancer in a patient by analysing gene expression
US10387406B2 (en) * 2011-03-10 2019-08-20 Mediseen Ehealth Ltd Method, system and program for improved health care
EP2715348B1 (en) * 2011-06-02 2019-04-10 Almac Diagnostic Services Limited Molecular diagnostic test for cancer
WO2012170513A2 (en) * 2011-06-06 2012-12-13 Women & Infants' Hospital Of Rhode Island He4 based therapy for malignant disease
CA2838736A1 (en) * 2011-06-07 2012-12-13 Caris Mpi, Inc. Molecular profiling for cancer
WO2012170710A1 (en) * 2011-06-08 2012-12-13 Altheadx Incorporated Disease classification modules
KR20140072014A (en) 2011-06-16 2014-06-12 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. Biomarker compositions and methods
WO2013030841A1 (en) * 2011-09-04 2013-03-07 Yissum Research Development Company Of The Hebrew Universitiy Of Jerusalem Ltd. Prognostic methods and compositions for predicting interferon treatment eficacy in a subject
EP2794911A1 (en) * 2011-12-22 2014-10-29 Aveo Pharmaceuticals, Inc. Identification of multigene biomarkers
EP2885640B1 (en) * 2012-08-16 2018-07-18 Genomedx Biosciences, Inc. Prostate cancer prognostics using biomarkers
MX2015006955A (en) * 2012-12-03 2016-01-25 Almac Diagnostics Ltd Molecular diagnostic test for cancer.
EA201591411A1 (en) * 2013-01-29 2016-01-29 Молекьюлар Хелт Гмбх SYSTEMS AND METHODS TO SUPPORT CLINICAL DECISIONS
EP2787670A1 (en) 2013-04-05 2014-10-08 Panasonic Intellectual Property Corporation of America MCS table adaptation for 256-QAM
US10679730B2 (en) * 2013-05-28 2020-06-09 The University Of Chicago Prognostic and predictive breast cancer signature
US10190169B2 (en) 2013-06-20 2019-01-29 Immunexpress Pty Ltd Biomarker identification
EP3019865A4 (en) * 2013-07-12 2017-04-05 Immuneering Corporation Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
WO2015073896A2 (en) 2013-11-15 2015-05-21 Psma Development Company, Llc Biomarkers for psma targeted therapy for prostate cancer
JP2017512304A (en) * 2014-02-06 2017-05-18 イミューンエクスプレス・プロプライエタリー・リミテッドＩｍｍｕｎｅＸｐｒｅｓｓ Ｐｔｙ Ｌｔｄ Biomarker signature method and apparatus and kit therefor
GB201409479D0 (en) * 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
US20150254433A1 (en) * 2014-03-05 2015-09-10 Bruce MACHER Methods and Models for Determining Likelihood of Cancer Drug Treatment Success Utilizing Predictor Biomarkers, and Methods of Diagnosing and Treating Cancer Using the Biomarkers
US20150317430A1 (en) 2014-05-05 2015-11-05 Advaita Corporation Systems and methods for analyzing biological pathways for the purpose of modeling drug effects, side effects, and interactions
FR3021776A1 (en) 2014-05-28 2015-12-04 Vaiomer METHOD FOR IDENTIFYING A RELATION BETWEEN PHYSICAL ELEMENTS
WO2016015095A1 (en) * 2014-07-31 2016-02-04 The University Of Western Australia A method for the identification of immunotherapy-drug combinations using a network approach
CN107109459A (en) 2014-11-05 2017-08-29 加利福尼亚大学董事会 For the method for the non-responder for being layered the therapy to blocking PD1/PDL1 axles
EP3240908A2 (en) 2014-12-30 2017-11-08 F. Hoffmann-La Roche AG Methods and compositions for prognosis and treatment of cancers
CA2986773A1 (en) * 2015-05-22 2016-12-01 Csts Health Care Inc. Biomarker-driven molecularly targeted combination therapies based on knowledge representation pathway analysis
EP3304093B1 (en) 2015-05-28 2023-12-27 Immunexpress Pty Ltd Validating biomarker measurement
EP3314020A1 (en) * 2015-06-29 2018-05-02 The Broad Institute Inc. Tumor and microenvironment gene expression, compositions of matter and methods of use thereof
GB201512869D0 (en) * 2015-07-21 2015-09-02 Almac Diagnostics Ltd Gene signature for minute therapies
US10835604B2 (en) * 2015-08-13 2020-11-17 Northeastern University Biomaterials for combined radiotherapy and immunotherapy of cancer
WO2017058999A2 (en) * 2015-09-29 2017-04-06 Crescendo Bioscience Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
WO2017059003A1 (en) * 2015-09-29 2017-04-06 Crescendo Bioscience Biomarkers and methods for assessing psoriatic arthritis disease activity
GB201521481D0 (en) 2015-12-04 2016-01-20 Healx Ltd Prognostic system
SG11201809317VA (en) * 2016-05-09 2018-11-29 Inst Nat Sante Rech Med Methods for classifying patients with a solid cancer
EP3523450A1 (en) * 2016-10-07 2019-08-14 Omniseq, Inc. Methods and systems for determining personalized therapies
AU2018342007A1 (en) 2017-08-07 2020-02-27 Board Of Regents, The University Of Texas Systems Methods and materials for assessing and treating cancer
US20200347456A1 (en) * 2017-10-02 2020-11-05 The Broad Institute, Inc. Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer

Patent Citations (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD496297S1 (en) * 2003-11-13 2004-09-21 Susan M. Kahil Face for a timepiece
USD697080S1 (en) * 2010-02-26 2014-01-07 Draeger Medical Systems, Inc. Display screen with an icon
US20120005631A1 (en) * 2010-06-30 2012-01-05 Oracle International Corporation Techniques for display of information related to policies
USD743413S1 (en) * 2012-09-19 2015-11-17 ABBYY InfoPiosk LLC Display screen or portion thereof with graphical user interface
USD719177S1 (en) * 2012-12-27 2014-12-09 Jason M. Cohen Display screen or portion thereof with graphical user interface
USD735732S1 (en) * 2013-03-12 2015-08-04 Hewlett-Packard Development Company, L.P. Display screen with graphical user interface
USD725148S1 (en) * 2013-04-30 2015-03-24 Microsoft Corporation Display screen with animated icon
USD741912S1 (en) * 2013-05-29 2015-10-27 Microsoft Corporation Display screen with animated graphical user interface
USD805535S1 (en) * 2013-06-04 2017-12-19 Abbyy Production Llc Display screen or portion thereof with a transitional graphical user interface
USD743424S1 (en) * 2013-06-04 2015-11-17 Abbyy Infopoisk Llc Display screen or portion thereof with graphical user interface
USD743423S1 (en) * 2013-06-04 2015-11-17 Abbyy Infopoisk Llc Display screen or portion thereof with graphical user interface
USD860251S1 (en) * 2013-06-09 2019-09-17 Apple Inc. Display screen or portion thereof with graphical user interface
USD755240S1 (en) * 2013-06-09 2016-05-03 Apple Inc. Display screen or portion thereof with graphical user interface
USD744500S1 (en) * 2013-07-05 2015-12-01 Lg Electronics Inc. Display screen with transitional graphical user interface
USD708193S1 (en) * 2013-08-30 2014-07-01 Nike, Inc. Display screen with graphical user interface
USD861020S1 (en) * 2013-09-10 2019-09-24 Apple Inc. Display screen or portion thereof with graphical user interface
USD809525S1 (en) * 2013-09-23 2018-02-06 Bally Gaming, Inc. Display screen with an animated graphical user interface for a baccarat game
USD863325S1 (en) * 2013-12-02 2019-10-15 Dials, LLC Display screen or portion thereof with a graphical user interface
USD771063S1 (en) * 2014-02-21 2016-11-08 Huawei Device Co., Ltd. Display screen or portion thereof with animated graphical user interface
USD711420S1 (en) * 2014-03-14 2014-08-19 Nike, Inc. Display screen with graphical user interface for athletic achievements
USD772241S1 (en) * 2014-03-19 2016-11-22 Symantec Corporation Display screen or portion thereof with transitional graphical user interface
USD759076S1 (en) * 2014-04-18 2016-06-14 Nutonian, Inc. Display screen with graphical user interface
USD850470S1 (en) * 2014-09-01 2019-06-04 Apple Inc. Display screen or portion thereof with graphical user interface
USD807906S1 (en) * 2014-09-01 2018-01-16 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD803849S1 (en) * 2014-09-02 2017-11-28 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD809543S1 (en) * 2014-09-02 2018-02-06 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD862503S1 (en) * 2014-09-02 2019-10-08 Apple Inc. Display screen or portion thereof with graphical user interface
USD801368S1 (en) * 2014-09-02 2017-10-31 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD859431S1 (en) * 2014-09-02 2019-09-10 Apple Inc. Display screen or portion thereof with graphical user interface
USD807905S1 (en) * 2014-09-02 2018-01-16 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD810110S1 (en) * 2014-09-02 2018-02-13 Apple Inc. Display screen or portion thereof with graphical user interface
USD797783S1 (en) * 2014-09-02 2017-09-19 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD765673S1 (en) * 2014-12-30 2016-09-06 Energous Corporation Display screen with graphical user interface
USD784402S1 (en) * 2015-02-04 2017-04-18 Sengled Optoelectronics Co., Ltd Display screen with animated graphical user interface
USD858531S1 (en) * 2015-03-06 2019-09-03 Apple Inc. Display screen or portion thereof with graphical user interface
USD873294S1 (en) * 2015-03-06 2020-01-21 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD809535S1 (en) * 2015-10-06 2018-02-06 Lg Electronics Inc. Vehicle dashboard display screen with an animated graphical user interface
USD855629S1 (en) * 2015-10-23 2019-08-06 Sony Corporation Display panel or screen or portion thereof with an animated graphical user interface
USD839290S1 (en) * 2015-10-28 2019-01-29 SynerScope B.V. Display screen with graphical user interface
USD783656S1 (en) * 2015-10-28 2017-04-11 SynerScope B.V. Display screen with graphical user interface
USD795922S1 (en) * 2015-11-05 2017-08-29 Samsung Electronics Co., Ltd. Display screen or portion thereof with animated graphical user interface
USD862519S1 (en) * 2015-11-18 2019-10-08 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD799516S1 (en) * 2015-12-23 2017-10-10 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD874488S1 (en) * 2016-01-05 2020-02-04 Kneevoice, Inc. Display screen or portion thereof with graphical user interface
USD879835S1 (en) * 2016-01-19 2020-03-31 Apple Inc. Display screen or portion thereof with set of icons
USD813888S1 (en) * 2016-02-04 2018-03-27 Coway Co., Ltd. Display screen with graphical user interface
USD810757S1 (en) * 2016-02-19 2018-02-20 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD803249S1 (en) * 2016-03-16 2017-11-21 Panasonic Intellectual Property Management Co., Ltd. Display screen portion with graphical user interface for a vehicle
USD807913S1 (en) * 2016-03-17 2018-01-16 Lg Electronics Inc. Display panel with transitional graphical user interface
USD802611S1 (en) * 2016-04-14 2017-11-14 Alpha Dominche Holdings, Inc. Beverage brewer display screen with graphical user interface
USD850482S1 (en) * 2016-06-11 2019-06-04 Apple Inc. Display screen or portion thereof with graphical user interface
USD835121S1 (en) * 2016-06-15 2018-12-04 Sony Interactive Entertainment Europe Limited Display screen or portion thereof with graphical user interface
USD882583S1 (en) * 2016-07-12 2020-04-28 Google Llc Display screen with graphical user interface
USD875748S1 (en) * 2016-08-15 2020-02-18 Facebook, Inc. Display screen or portion thereof with digital visual code graphical user interface
USD840413S1 (en) * 2016-08-15 2019-02-12 Facebook, Inc. Display screen or portion thereof with digital visual codes graphical user interface
USD852209S1 (en) * 2016-08-24 2019-06-25 Beijing Kingsoft Internet Security Software Co., Ltd. Mobile communication terminal with animated graphical user interface
USD813250S1 (en) * 2016-08-30 2018-03-20 Ponsse Oyj Display screen with graphical user interface
USD868831S1 (en) * 2016-10-31 2019-12-03 Agile Transformation, Inc. Display screen or portion thereof with icon
USD831697S1 (en) * 2016-10-31 2018-10-23 Agile Transformation, Inc. Display screen or portion thereof with icon
USD806120S1 (en) * 2016-10-31 2017-12-26 Agile Transformation, Inc. Display screen or portion thereof with icon
USD847857S1 (en) * 2016-10-31 2019-05-07 Agile Transformation, Inc. Display screen or portion thereof with icon
USD829730S1 (en) * 2016-11-10 2018-10-02 Karma Automotive Llc Display screen with an infotainment graphical user interface
USD865776S1 (en) * 2016-11-18 2019-11-05 Luis Miguel Porturas Display screen with graphical user interface
USD813249S1 (en) * 2017-02-22 2018-03-20 Banuba Limited Display screen with an animated graphical user interface
USD832283S1 (en) * 2017-03-28 2018-10-30 Akamai Technologies, Inc. Display screen with animated graphical user interface
USD822705S1 (en) * 2017-04-20 2018-07-10 Palantir Technologies, Inc. Display screen or portion thereof with graphical user interface
USD880489S1 (en) * 2017-05-18 2020-04-07 The Coca-Cola Company Beverage dispenser display screen or portion thereof with animated graphical user interface
USD818494S1 (en) * 2017-06-04 2018-05-22 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD841690S1 (en) * 2017-06-04 2019-02-26 Apple Inc. Display screen or portion thereof with icon
USD879145S1 (en) * 2017-06-05 2020-03-24 Apple Inc. Display screen or portion thereof with animated graphical user interface
USD822059S1 (en) * 2017-06-05 2018-07-03 Apple Inc. Display screen or portion thereof with graphical user interface
US20180357378A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for generating, visualizing and classifying molecular functional profiles
US10340031B2 (en) 2017-06-13 2019-07-02 Bostongene Corporation Systems and methods for identifying cancer treatments from normalized biomarker scores
US20180357374A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for generating, visualizing and classifying molecular functional profiles
US20180358125A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for identifying cancer treatments from normalized biomarker scores
US20180358132A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for identifying cancer treatments from normalized biomarker scores
US20180358118A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for identifying cancer treatments from normalized biomarker scores
US20180357377A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for generating, visualizing and classifying molecular functional profiles
US10311967B2 (en) * 2017-06-13 2019-06-04 Bostongene Corporation Systems and methods for generating, visualizing and classifying molecular functional profiles
US20180357376A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for generating, visualizing and classifying molecular functional profiles
US20180357373A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for generating, visualizing and classifying molecular functional profiles
US20190179998A9 (en) 2017-06-13 2019-06-13 Bostongene Corporation Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
US20180358128A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for identifying cancer treatments from normalized biomarker scores
US20180357372A1 (en) 2017-06-13 2018-12-13 Alexander Bagaev Systems and methods for generating, visualizing and classifying molecular functional profiles
US10340030B2 (en) 2017-06-13 2019-07-02 Bostongene Corporation Systems and methods for identifying cancer treatments from normalized biomarker scores
US20180357361A1 (en) 2017-06-13 2018-12-13 Feliks Frenkel Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy
USD879808S1 (en) * 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
USD833471S1 (en) * 2017-08-18 2018-11-13 Salesforce.Com, Inc. Display screen or portion thereof with animated graphical user interface
USD871437S1 (en) * 2017-08-22 2019-12-31 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD840415S1 (en) * 2017-08-25 2019-02-12 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD860228S1 (en) * 2017-09-05 2019-09-17 Byton Limited Display screen with a graphical user interface
USD868103S1 (en) * 2017-09-27 2019-11-26 Toyota Research Institute, Inc. Display screen or portion thereof with an animated graphical user interface
USD861022S1 (en) * 2017-10-13 2019-09-24 Honeywell International Inc. Display screen or portion thereof with a graphical user interface
USD879112S1 (en) * 2017-11-14 2020-03-24 Geographic Services, Inc. Display screen or portion thereof with graphical user interface
USD873854S1 (en) * 2017-11-24 2020-01-28 Fujifilm Corporation Display screen or portion thereof with transitional icon
USD870763S1 (en) * 2018-01-05 2019-12-24 Samsung Electronics Co., Ltd. Display screen or portion thereof with graphical user interface
USD852820S1 (en) * 2018-01-19 2019-07-02 Mouth Player Inc. Display screen or portion thereof with animated graphical user interface
USD878393S1 (en) * 2018-01-30 2020-03-17 Magic Leap, Inc. Display panel or portion thereof with a transitional mixed reality graphical user interface
USD868812S1 (en) * 2018-02-16 2019-12-03 Early Warning Services, Llc Display screen portion with animated graphical user interface for transmittal notification
USD868811S1 (en) * 2018-02-22 2019-12-03 Samsung Electronics Co., Ltd. Display screen or portion thereof with transitional graphical user interface
USD874482S1 (en) * 2018-02-28 2020-02-04 Fujifilm Corporation Display screen or portion thereof with icon
USD877176S1 (en) * 2018-07-24 2020-03-03 Magic Leap, Inc. Display panel or portion thereof with a transitional graphical user interface
USD865807S1 (en) * 2018-07-24 2019-11-05 Magic Leap, Inc. Display panel or portion thereof with a graphical user interface
USD879147S1 (en) * 2018-07-31 2020-03-24 Google Llc Display screen with animated icon
USD868094S1 (en) * 2018-08-30 2019-11-26 Apple Inc. Electronic device with graphical user interface
USD882615S1 (en) * 2018-09-06 2020-04-28 Apple Inc. Electronic device with animated graphical user interface
USD855073S1 (en) * 2019-04-05 2019-07-30 Le-Vel Brands, Llc Display screen with icon

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
U.S. Appl. No. 29/694,302, filed Jun. 10, 2019, Bagaev.
U.S. Appl. No. 29/694,305, filed Jun. 10, 2019, Bagaev.
U.S. Appl. No. 29/694,310, filed Jun. 10, 2019, Bagaev.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWD216917S (en) 2020-12-11 2022-02-01 股感媒體科技股份有限公司 Graphical User Interface for Display Panel

Also Published As

Publication number Publication date
CN111033631B (en) 2024-03-12
US10636513B2 (en) 2020-04-28
US20200098443A1 (en) 2020-03-26
US10706954B2 (en) 2020-07-07
US11842797B2 (en) 2023-12-12
KR102396784B1 (en) 2022-05-13
US10311967B2 (en) 2019-06-04
WO2018231772A1 (en) 2018-12-20
US20200058377A1 (en) 2020-02-20
US20180358118A1 (en) 2018-12-13
US11430545B2 (en) 2022-08-30
EP3639170B1 (en) 2021-03-24
JP2020528268A (en) 2020-09-24
US20200175133A9 (en) 2020-06-04
US10340031B2 (en) 2019-07-02
US10340030B2 (en) 2019-07-02
US20180358132A1 (en) 2018-12-13
US20180357374A1 (en) 2018-12-13
CN111033631A (en) 2020-04-17
GB2576857A (en) 2020-03-04
GB2576857B (en) 2022-12-07
JP7343565B2 (en) 2023-09-12
US20190325993A1 (en) 2019-10-24
JP7408534B2 (en) 2024-01-05
US10580517B2 (en) 2020-03-03
JP2020523705A (en) 2020-08-06
US10395761B1 (en) 2019-08-27
IL270888A (en) 2020-01-30
AU2018102201A4 (en) 2021-01-21
US20180358128A1 (en) 2018-12-13
GB202201288D0 (en) 2022-03-16
US11322226B2 (en) 2022-05-03
DE112018002990T5 (en) 2020-04-02
GB2577828A (en) 2020-04-08
CA3066004A1 (en) 2018-12-20
GB2601923B8 (en) 2023-03-08
JP7034183B2 (en) 2022-03-11
US11367509B2 (en) 2022-06-21
US20200175134A9 (en) 2020-06-04
US11004542B2 (en) 2021-05-11
US20180357376A1 (en) 2018-12-13
KR20200028388A (en) 2020-03-16
US20200273543A1 (en) 2020-08-27
CA3065568A1 (en) 2018-12-20
US11302420B2 (en) 2022-04-12
US20180357378A1 (en) 2018-12-13
US20180357373A1 (en) 2018-12-13
US20210249107A9 (en) 2021-08-12
GB2601923A8 (en) 2023-03-08
JP6776464B2 (en) 2020-10-28
CA3065193A1 (en) 2018-12-20
AU2018282865A1 (en) 2019-12-19
EP3639170A1 (en) 2020-04-22
GB2601923B (en) 2023-01-04
GB202209539D0 (en) 2022-08-10
US20220389512A1 (en) 2022-12-08
US10504615B2 (en) 2019-12-10
IL270887A (en) 2020-01-30
WO2018231771A1 (en) 2018-12-20
US20200005903A1 (en) 2020-01-02
AU2018284077A1 (en) 2020-01-02
US20200335180A1 (en) 2020-10-22
US11373733B2 (en) 2022-06-28
US20200175135A9 (en) 2020-06-04
SG10201911541YA (en) 2020-02-27
US20190252046A1 (en) 2019-08-15
US20200075131A1 (en) 2020-03-05
AU2018282759A2 (en) 2021-01-07
GB2601923A (en) 2022-06-15
US20190332744A9 (en) 2019-10-31
US10650911B2 (en) 2020-05-12
CN111052247A (en) 2020-04-21
JP2022050445A (en) 2022-03-30
GB201918335D0 (en) 2020-01-29
US10636514B2 (en) 2020-04-28
US10720230B2 (en) 2020-07-21
US20190243943A9 (en) 2019-08-08
WO2018231762A8 (en) 2019-12-19
JP7401710B2 (en) 2023-12-19
US20210257058A1 (en) 2021-08-19
EP3639169B1 (en) 2022-03-23
US11705220B2 (en) 2023-07-18
JP6812580B2 (en) 2021-01-13
SG10201911680SA (en) 2020-02-27
US20180357372A1 (en) 2018-12-13
EP4012713A1 (en) 2022-06-15
EP3639172A1 (en) 2020-04-22
US20180357377A1 (en) 2018-12-13
EP3639172B1 (en) 2021-03-31
AU2018282759A1 (en) 2020-01-02
JP2021072778A (en) 2021-05-13
JP6999771B2 (en) 2022-02-04
EP3879535A1 (en) 2021-09-15
JP2023169202A (en) 2023-11-29
JP2020523028A (en) 2020-08-06
JP2021036868A (en) 2021-03-11
US20240006029A1 (en) 2024-01-04
US20190179998A9 (en) 2019-06-13
GB2576680B (en) 2022-03-23
USD890779S1 (en) 2020-07-21
GB2576680A (en) 2020-02-26
US20180358125A1 (en) 2018-12-13
US20180357361A1 (en) 2018-12-13
WO2018231762A1 (en) 2018-12-20
AU2018284077B2 (en) 2021-09-23
JP2024029038A (en) 2024-03-05
US20200265924A1 (en) 2020-08-20
GB201918035D0 (en) 2020-01-22
US20200135302A1 (en) 2020-04-30
EP3639169A1 (en) 2020-04-22
GB201918389D0 (en) 2020-01-29
IL270886A (en) 2020-01-30
US20180357362A1 (en) 2018-12-13

Similar Documents

Publication Publication Date Title
USD890779S1 (en) Display screen or portion thereof with graphical user interface
USD931893S1 (en) Display screen or a portion thereof with a graphical user interface
USD1013719S1 (en) Display screen or portion thereof with graphical user interface
USD951971S1 (en) Display screen or portion thereof with a graphical user interface
USD968444S1 (en) Display screen with graphical user interface
USD843403S1 (en) Display screen or portion thereof with graphical user interface
USD845321S1 (en) Display screen or a portion thereof with graphical user interface
USD839888S1 (en) Display screen or portion thereof with graphical user interface
USD877164S1 (en) Display screen or portion thereof with a graphical user interface
USD966298S1 (en) Display screen or portion thereof with graphical user interface
USD819675S1 (en) Display screen or portion thereof with a graphical user interface
USD843402S1 (en) Display screen or portion thereof with graphical user interface
USD845314S1 (en) Display screen or portion thereof with graphical user interface
USD817351S1 (en) Display screen or portion thereof with graphical user interface
USD839904S1 (en) Display screen or portion thereof with graphical user interface
USD817339S1 (en) Display screen or portion thereof with graphical user interface
USD847837S1 (en) Display screen with graphical user interface
USD819056S1 (en) Display screen or portion thereof with graphical user interface
USD820869S1 (en) Display screen or portion thereof with a graphical user interface
USD845970S1 (en) Display screen or portion thereof with a graphical user interface
USD967157S1 (en) Display screen or portion thereof with graphical user interface
USD928819S1 (en) Display screen portion with a graphical user interface
USD817349S1 (en) Display screen or portion thereof with graphical user interface
USD817350S1 (en) Display screen or portion thereof with graphical user interface
USD967843S1 (en) Display screen or portion thereof with a graphical user interface

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY